NCT03598309 2026-02-27
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT06626230 2025-04-23
Safety of Anal Curcumin
Emory University
Phase 1 Recruiting
NCT00118989 2017-04-20
Curcumin for the Chemoprevention of Colorectal Cancer
University of Pennsylvania
Phase NA Terminated
NCT01042938 2012-06-25
Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
University of Rochester
Phase 2 Completed